Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107778083 | 10777808 | 3 | F | 20050809 | 20160825 | 20150209 | 20160830 | EXP | US-PFIZER INC-2015048457 | PFIZER | 55.00 | YR | F | Y | 67.00000 | KG | 20160830 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107778083 | 10777808 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, 1X/DAY | 25220 | MG | U | 20702 | 10 | MG | FILM-COATED TABLET | QD | |||
| 107778083 | 10777808 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, 1X/DAY | 25220 | MG | U | 20702 | 20 | MG | FILM-COATED TABLET | QD | |||
| 107778083 | 10777808 | 3 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, 1X/DAY | 25220 | MG | U | 20702 | 20 | MG | FILM-COATED TABLET | QD | |||
| 107778083 | 10777808 | 4 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, 1X/DAY | 25220 | MG | U | 20702 | 40 | MG | FILM-COATED TABLET | QD | |||
| 107778083 | 10777808 | 5 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, 1X/DAY | 25220 | MG | U | 20702 | 20 | MG | FILM-COATED TABLET | QD | |||
| 107778083 | 10777808 | 6 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, 1X/DAY | 25220 | MG | U | 20702 | 40 | MG | FILM-COATED TABLET | QD | |||
| 107778083 | 10777808 | 7 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 80 MG, 1X/DAY | 25220 | MG | U | 20702 | 80 | MG | FILM-COATED TABLET | QD | |||
| 107778083 | 10777808 | 8 | SS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | 80 MG, 1X/DAY | N | 20702 | 80 | MG | FILM-COATED TABLET | QD | ||||||
| 107778083 | 10777808 | 9 | SS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | 40 MG, 1X/DAY | N | 20702 | 40 | MG | FILM-COATED TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107778083 | 10777808 | 1 | Blood cholesterol increased |
| 107778083 | 10777808 | 2 | Low density lipoprotein increased |
| 107778083 | 10777808 | 3 | Cardiovascular event prophylaxis |
| 107778083 | 10777808 | 8 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107778083 | 10777808 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107778083 | 10777808 | Colitis ischaemic | |
| 107778083 | 10777808 | Nephropathy | |
| 107778083 | 10777808 | Neuropathy peripheral | |
| 107778083 | 10777808 | Stress | |
| 107778083 | 10777808 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107778083 | 10777808 | 1 | 19990308 | 19990609 | 0 | |
| 107778083 | 10777808 | 2 | 19990609 | 20021004 | 0 | |
| 107778083 | 10777808 | 3 | 20040319 | 20050511 | 0 | |
| 107778083 | 10777808 | 4 | 20050511 | 20060504 | 0 | |
| 107778083 | 10777808 | 5 | 20060504 | 20070219 | 0 | |
| 107778083 | 10777808 | 6 | 20070219 | 20070807 | 0 | |
| 107778083 | 10777808 | 7 | 20070807 | 20120111 | 0 | |
| 107778083 | 10777808 | 8 | 20120111 | 20120312 | 0 | |
| 107778083 | 10777808 | 9 | 20120312 | 20131008 | 0 |